Company Filing History:
1 out of 832,912 Years Active: 2019
Title: Hsuan-Hsuan Lu: Innovator in Cancer Treatment
Introduction
Hsuan-Hsuan Lu is a prominent inventor based in Taipei, Taiwan. She has made significant contributions to the field of cancer research, particularly in developing innovative therapies for treating human lung cancer. Her work focuses on utilizing small RNAs as anti-cancer drugs, showcasing her commitment to advancing medical science.
Latest Patents
Hsuan-Hsuan Lu holds a patent for her invention titled "Composition and method of using miR-302 precursors as anti-cancer drugs for treating human lung cancer." This invention relates to a composition and method of using man-made small RNAs, such as small interfering RNAs (siRNA), microRNAs (miRNA), and their hairpin-like precursors (pre-miRNA), as tumor-suppressing anti-cancer drugs. The invention aims to treat various human tumors and cancers, including skin (melanoma), blood (leukemia), prostate, breast, liver, and lung cancers, as well as various neoplastic tumors.
Career Highlights
Throughout her career, Hsuan-Hsuan Lu has demonstrated exceptional expertise in the field of molecular biology and oncology. Her innovative approach to cancer treatment has positioned her as a leading figure in the development of novel medicines and therapies. She has successfully contributed to the scientific community through her research and patent filings.
Collaborations
Hsuan-Hsuan Lu has collaborated with notable colleagues, including Shi-Lung Lin and Donald C Chang. These partnerships have further enhanced her research efforts and contributed to the advancement of cancer treatment methodologies.
Conclusion
Hsuan-Hsuan Lu's work in developing anti-cancer drugs using miR-302 precursors represents a significant advancement in cancer therapy. Her innovative contributions continue to inspire future research in the field of oncology.